Pain Therapeutics to Present at the Credit Suisse Healthcare Conference

• Press Release
• Source: Pain Therapeutics, Inc.
• On 9:00 am EST, Wednesday November 4, 2009

SAN MATEO, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE - News) today announced that management will present at the Credit Suisse Healthcare Conference on Wednesday, November 11th at 2:30 p.m. Mountain Standard Time.

Related Quotes

Symbol	Price	Change
PTIE	4.80	+0.05

{"s" : "ptie","k" : "c10,l10,p20,t10","o" : "","j" : ""}

A live audio webcast of the presentation will be available on the company's website homepage at www.paintrials.com. A replay of the audio webcast will continue to be available on the website for thirty days.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Our lead drug candidate, Remoxy(R), is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. We are also developing novel drugs in the area of hematology/oncology. In clinical development we have a monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. We have in pre-clinical development a drug to treat hemophilia, a genetic disorder in which patients are unable to stop bleeding. The FDA has not approved any of our drug candidates for commercial sale. For more information, please visit www.paintrials.com.

Pain Therapeutics, Inc.
Judy Ishida, Administrative Manager
650-645-1924 
IR@paintrials.com